Drug Channels

NOVEMBER 16, 2021

In Consolidation and Preferred Pharmacy Networks in 2022’s Medicare Part D Plans , I highlighted how those networks have hijacked the world of stand-alone Medicare Part D prescription drug plans (PDP) and become a major presence in Medicare Advantage prescription drug (MA-PD) plans. Today, I examine the largest retail chains’ participation in the 21 major 2022 Part D preferred networks that the eight largest plan sponsors will offer.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Patent Watch

NOVEMBER 10, 2021

Annual Drug Patent Expirations for ARISTADA+INITIO+KIT Aristada Initio Kit is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Alkermes Inc drug ARISTADA INITIO KIT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Drug Discovery Today

NOVEMBER 9, 2021

Innovate UK grant awarded for the development of quantum computing in cancer treatment

Treatment 113

Treatment Drugs 113

The Pharma Data

NOVEMBER 29, 2021

Amgen Ranks in Top 10% of Biotechnology Companies Worldwide, Earning Top Scores in Business Ethics, Philanthropy, and Environmental Reporting. Amgen today announced that it has been named to the Dow Jones Sustainability World Index for the eighth consecutive year, reflecting the company’s enduring commitment to environmental, social, and governance (ESG) issues.

Government 52

Government Clinical Trials Science Trials 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

ProRelix Research

NOVEMBER 17, 2021

Covid 19 Booster Dose – Should we consider it? The idea of booster doses for Covid-19 vaccinations is gaining traction around the world, but India remains a skeptic. Various countries, […]. The post Covid 19 Booster Dose – Should we consider it? appeared first on ProRelix Research.

Vaccine 52

Vaccine Research 52

NIH Director's Blog: Drug Development

NOVEMBER 16, 2021

Credit: Fizkes/Shutterstock Over the course of this pandemic, significant progress has been made in treating COVID-19 and helping to save lives. That progress includes the development of life-preserving monoclonal antibody infusions and repurposing existing drugs , to which NIH’s Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV ) public-private partnership has made a major contribution.

Clinical Trials 52

Clinical Trials Virus Hospitals FDA 52

Drug Patent Watch

NOVEMBER 30, 2021

Annual Drug Patent Expirations for FLOVENT+HFA Flovent Hfa is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from four suppliers. There are…. The post New patent expiration for Glaxo Grp drug FLOVENT HFA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Creative Biolabs

NOVEMBER 14, 2021

Vascular dysfunction contributes to the pro-oncogenic tumor microenvironment and impedes the delivery of therapeutic drugs, so normalizing tumor blood vessels may become a potential path. Scientists have developed a new type of therapeutic antibody that may dredge and normalize blood vessels in cancerous tumors, thus providing a more effective drug delivery pathway for targeted cancer treatments, according to a study published on bioRxiv.

Drugs 52

Drugs Therapies Treatment Research 52

The Pharma Data

NOVEMBER 29, 2021

Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla ® (apremilast) and placebo in treating adults with moderate to severe plaque psoriasis. U.S. Food and Drug Administration assigned a target action date of September 10, 2022; European Medicines Agency validation confirms the submission is complete and begins the centralized review process.

Treatment 52

Treatment Clinical Trials Trials FDA 52

Plenge Gen

NOVEMBER 15, 2021

[Disclaimers: I am an employee of Bristol Myers Squibb. The views expressed here are my own. Also, I am not a particularly good poker or chess player. It is one reason I am a popular invited guest to poker nights with friends.] I posted on poll on Twitter to ask the question is drug discovery more like poker or chess. There were over 300 responses, with the results split nearly equally (54% poker, 46% chess).

Drugs 52

Drugs 52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Crown Bioscience

NOVEMBER 12, 2021

In this post, we explore how a targeted RNA-Sequencing (RNA-Seq) panel can be incorporated into preclinical drug development to evaluate the impact of immune effectors in mediating anti-tumor immunity of novel immuno-oncology (I/O) agents. A case study highlights how RNA-Seq panels can complement traditional protein-based assays to gain a truly comprehensive picture of novel immunotherapies.

RNA 52

RNA Drug Development Drugs 52

Drug Channels

NOVEMBER 19, 2021

Today’s guest post comes from Carolyn Zele, Senior Manager of Solution Enablement at MMIT. Carolyn describes how oncology pathways were developed to help standardize treatment and ensure quality care. She argues, however, that these pathways often shut manufacturers out of the market. Click here to learn more about MMIT's Pulse Analytics solution , which provides insight into payer- and pathway-driven barriers to access.

Treatment 98

Treatment Marketing Drugs 98

Drug Patent Watch

NOVEMBER 14, 2021

Annual Drug Patent Expirations for AMTURNIDE Amturnide is a drug marketed by Novartis and is included in one NDA. There are two patents protecting this drug. This drug has one…. The post New patent expiration for Novartis drug AMTURNIDE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Tebu Bio: Drug Discovery

NOVEMBER 12, 2021

Many researchers are facing the challenges of mRNA delivery, through the body into the cytoplasm of cells. In this post, we invite you to discover some useful and efficient solutions to improve and control all the steps of your mRNA delivery project.

RNA 52

RNA Research Drugs 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

The Pharma Data

NOVEMBER 29, 2021

First Combination of Immunotherapy With Tyrosine Kinase Inhibitor Approved in Europe for Adult Patients With Advanced or Recurrent Endometrial Carcinoma With Disease Progression on or Following Prior Treatment With a Platinum-Containing Therapy in Any Setting and Who Are Not Candidates for Curative Surgery or Radiation. Approval Based on KEYNOTE-775/Study 309 Results Demonstrating Statistically Significant Improvements in Overall Survival and Progression-Free Survival Compared With Chemotherapy.

Treatment 52

Treatment RNA Pharmaceutical Companies Vaccine 52

Olympian Clinical Research

NOVEMBER 10, 2021

If you’ve been suffering from plaque psoriasis for a while, you may be frustrated and eager for something that can help. Living with plaque psoriasis can be difficult, and you might not know where to turn or who can help. Fortunately, there are tips and treatment options available to you to help lessen your symptoms. Symptoms of Plaque Psoriasis.

Clinical Research 52

Clinical Research Treatment Disease Therapies 52

ProRelix Research

NOVEMBER 9, 2021

Use of Social Media and Mobile Devices – Study Participants Recruitment There has been a significant change in the clinical trial and advertising industries over the last five years that […]. The post Use of Social Media and Mobile Devices – Study Participants Recruitment appeared first on ProRelix Research.

Clinical Trials 52

Clinical Trials Trials Research 52

Drug Channels

NOVEMBER 30, 2021

ICYMI, CVS Health recently announced that it will close about 900 of its retail pharmacies. This downsizing complements the company’s shift toward its healthcare delivery future. This long-overdue move highlights the retail industry’s fundamental economic headwinds. The pharmacy shakeout is accelerating, as smaller competitors exit and larger companies reduce store count.

Pharmacy 98

Pharmacy Drugs 98

Drug Patent Watch

NOVEMBER 26, 2021

Annual Drug Patent Expirations for VIBERZI Viberzi is a drug marketed by Allergan Holdings and is included in one NDA. It is available from one supplier. There are sixteen patents…. The post New patent for Allergan Holdings drug VIBERZI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98

Drugs Marketing 98

Practical Cheminformatics

NOVEMBER 30, 2021

Here's a quick post based on a conversation with a friend who wanted to be able to cluster a set of docked molecules based on fingerprints and select the highest scoring molecule(s) from each cluster. As usual, Pandas made this super easy. The code for this example can be run on Colab and is also available as a Gist.

40

40

The Pharma Data

NOVEMBER 29, 2021

On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves, for example, on how easily it spreads or the severity of illness it causes.

Vaccine 52

Vaccine Virus Hospitals Disease 52

Olympian Clinical Research

NOVEMBER 1, 2021

Overcoming social anxiety is a process that takes time and commitment, often beginning in the early ages of childhood and adolescence. Social Anxiety Disorder (SAD) affects 15 million American adults and is prevalent in an estimated 9.1% of adolescents between the ages of 13 and 18. Most children experience an onset of SAD between the ages of eight and 15, and it can be triggered by a traumatic experience or emerge from a natural tendency of shyness. .

Doctors 52

Doctors Clinical Research Research 52

The Anticancer Fund

NOVEMBER 26, 2021

26 November 2021 Language EN Drug repurposing is a strategy for identifying new uses for approved drugs, outside the scope of the original indication. It is one of the focus areas of the Anticancer Fund. Below, we have listed recent findings about the repurposing of generic drugs in oncology. Our intention is to help bring these findings to the attention of the broader cancer research community.

Clinical Trials 40

Clinical Trials Drugs Trials Treatment 40

Drug Channels

NOVEMBER 18, 2021

In my previous post , I highlighted the largest pharmacy chains that will participate in the 2022 Medicare Part D prescription drug plans (PDP). Today, I examine how smaller pharmacies will participate as preferred cost sharing pharmacies via the pharmacy services administrative organizations (PSAOs) that represent them in negotiations with plans. As you will see here, the largest PSAOs are increasingly rejecting preferred networks.

Pharmacy 75

Pharmacy Drugs 75

Drug Patent Watch

NOVEMBER 4, 2021

Annual Drug Patent Expirations for MYCAPSSA Mycapssa is a drug marketed by Chiasma and is included in one NDA. It is available from one supplier. There are seven patents protecting…. The post New patent for Chiasma drug MYCAPSSA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Nvidia Developer: Drug Discovery

NOVEMBER 3, 2021

Computational molecular design involves compute-intense calculations that require exceptional processing power. Whether working in pharmaceuticals, Computational molecular design involves compute-intense calculations that require exceptional processing power. Whether working in pharmaceuticals, biotechnology, agrochemicals, or the fragrance industry, researchers are oftentimes dealing with datasets that encompass millions to billions of compounds.

Drugs 52

Drugs Pharmaceuticals Production Research 52

The Pharma Data

NOVEMBER 29, 2021

Since the emergence of the COVID-19 epidemic, Johnson & Johnson (the Company) has been nearly covering recently arising COVID-19 variants. In collaboration with academic groups in South Africa and around the world, the Company has been assessing the effectiveness of its COVID-19 vaccine across variants, including now the new and fleetly spreading Omicron variant.

Vaccine 52

Vaccine Hospitals Disease Research 52

Eye on FDA

NOVEMBER 18, 2021

In what has been a glacially paced nomination process, the Biden Administration announced on November 12 that it would, in fact, be nominating Dr. Robert Califf to return to his role as FDA Commissioner. Acting Comissioner Janet Woodcock indicated in a tweet that she would be remaining in the role of Acting Commissioner during the confirmation process.

FDA 57

FDA Pharmaceuticals Pharmaceutical Companies Clinical Research 57

The Strateos Blog: Drug Discovery

NOVEMBER 1, 2021

Between October 11-13th, Strateos was a proud participant at the 20/15 Visioneers Cloud Lab, HTE, Lab Automation Virtual Conference alongside other thought leaders in the space such as PerkinElmer, Dotmatics and Gingko Bioworks. The theme of the conference was how laboratory automation, HTE, and cloud labs are enabling model-quality data generation to drive better, more efficient experimentation to accelerate scientific discoveries.

Laboratories 52

Laboratories Science Production Research 52

Drug Channels

NOVEMBER 23, 2021

Happy Thanksgiving, everyone! Before you stretch your stomach, stretch your mind with our extra-stuffed helping of food for thought. In this issue: The State of Specialty Pharmacy 2021 How health plans profit—and patients lose—from insulin A fantastic new analysis of the gross-to-net bubble Reconsidering Amazon P.S. Please join the nearly 13,000 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Biosimilars Drugs 98

Drug Patent Watch

NOVEMBER 4, 2021

Annual Drug Patent Expirations for SAVELLA Savella is a drug marketed by Allergan and is included in one NDA. It is available from three suppliers. There are four patents protecting…. The post New patent expiration for Allergan drug SAVELLA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Drug Channels

NOVEMBER 9, 2021

The Food & Drug Administration (FDA) recently approved the first interchangeable biosimilar insulin product: the insulin glargine-yfgn injection from Viatris. Read the FDA’s press release. Alas, I’m sad to report that the warped incentives baked into the U.S. drug channel will limit the impact of this impressive breakthrough. Viatris is being forced to launch both a high-priced and a low-priced version of the biosimilar.

Biosimilars 98

Biosimilars Production FDA Drugs 98

Drug Channels

NOVEMBER 8, 2021

Informa Connect’s Trade & Channel Strategies. Delivered as a Hybrid Event In-Person: December 13-14, 2021, Hilton Philadelphia at Penn’s Landing, Philadelphia, PA Virtual: December 16-17, 2021 [link]. The full agenda for this year’s Trade and Channel Strategies conference is available now! Year after year, the life science industry marks Informa Connect’s Trade and Channel Strategies as the “go-to” event for trade, channel, market access, account strategy and brand professionals.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Biosimilars Marketing 75

Drug Channels

NOVEMBER 5, 2021

Today’s guest post comes from Ashleigh Burdette, Senior Director of Clinical Innovation at Biologics by McKesson. Ashleigh explains how biopharma companies can help patients become more adherent and achieve better health outcomes by partnering with an experienced specialty pharmacy that offers risk-based care. . To learn more about the risk-based care approach, download the free whitepaper: Risk-Based Care Helps Cancer Treatment Adherence.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Treatment Drugs 75